Medical Devices · Rockville, Maryland, United States
$1.33
+4.72% (+$0.06)2026-07-09
Smart-Money SignalNeutral · 52/100— Insider open-market flow is flat over 90 days
Revenue$4.5M
Net Income-$4.8M
EPS$-0.04
Gross Margin179.6%
Market Cap$142.5M
Price Performance
Historical data including institutional events
Company Profile
M
Maher Masoud
CEO & Executive Director
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
- Founded
- 1999
- Employees
- 91
- Headquarters
- Rockville, Maryland, United States
- Website
- www.maxcyte.com
Peer ComparisonRevenue ($B)
▾Loading company sections...